Mikio Hayashi Selected Research

monosodium(2- (6- hydroxynaphthalen- 2- yl)- 6- methylpyrimidin- 4- yloxy)acetate dihydrate

6/2002

Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mikio Hayashi Research Topics

Disease

8	Neoplasms (Cancer) 06/2022 - 12/2008
4	Prostatic Neoplasms (Prostate Cancer) 04/2014 - 11/2007
3	Inflammation (Inflammations) 04/2021 - 01/2018
3	Venous Thrombosis (Deep-Vein Thrombosis) 05/2005 - 06/2002
2	Glioblastoma (Glioblastoma Multiforme) 07/2021 - 01/2020
2	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2021 - 01/2018
2	Atopic Dermatitis (Atopic Eczema) 02/2020 - 01/2018
2	Hot Flashes 04/2014 - 03/2009
2	Pain (Aches) 08/2012 - 12/2008
2	Osteoporosis 10/2011 - 03/2011
1	Leiomyosarcoma 06/2022
1	Sarcoma (Soft Tissue Sarcoma) 06/2022
1	Dementia (Dementias) 01/2022
1	Glioma (Gliomas) 07/2021
1	Contact Dermatitis (Eczema, Contact) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Pruritus (Itching) 02/2020
1	Disease Progression 01/2020
1	Insulin Resistance 01/2019
1	Dermatitis 01/2018
1	Cholera 12/2016
1	Diarrhea 12/2016
1	Hyperalgesia 08/2012
1	Hyperthermia 08/2012
1	Overactive Urinary Bladder (Overactive Bladder) 01/2011
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2011
1	Flushing 03/2009
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2005
1	Brain Infarction 05/2005
1	Carcinoma in Situ 06/2004
1	Transitional Cell Carcinoma 06/2004
1	Carcinoma (Carcinomatosis) 10/2002
1	Non-Muscle Invasive Bladder Neoplasms 10/2002
1	Hemorrhage 09/2002

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2018 - 03/2011
3	AndrogensIBA 04/2014 - 12/2008
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 04/2014 - 12/2008
3	bicalutamide (Casodex)FDA LinkGeneric 04/2014 - 12/2008
2	delgocitinibIBA 02/2020 - 01/2018
2	Janus Kinase InhibitorsIBA 02/2020 - 01/2018
2	Androgen Antagonists (Antiandrogens)IBA 04/2014 - 03/2009
2	Chlormadinone Acetate (Chlormadinone)IBA 04/2014 - 03/2009
2	Calcium-Sensing ReceptorsIBA 10/2011 - 03/2011
1	Proteins (Proteins, Gene)FDA Link 07/2021
1	Imiquimod (Aldara)FDA LinkGeneric 04/2021
1	Phosphotransferases (Kinase)IBA 04/2021
1	resiniferatoxinIBA 01/2021
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2021
1	LigandsIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Inducible T-Cell Co-Stimulator LigandIBA 01/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 12/2019
1	AntioxidantsIBA 12/2019
1	Insulin (Novolin)FDA Link 12/2019
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 10/2019
1	Propofol (Diprivan)FDA LinkGeneric 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Intravenous AnestheticsIBA 01/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2018
1	InterleukinsIBA 01/2018
1	Janus KinasesIBA 01/2018
1	Interleukin-23 (Interleukin 23)IBA 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	CytokinesIBA 01/2018
1	HaptensIBA 01/2018
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2018
1	Thymic Stromal LymphopoietinIBA 01/2018
1	Immunoglobulin E (IgE)IBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Ointments (Pastes)IBA 01/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2016
1	Ace toxinIBA 12/2016
1	AnoctaminsIBA 12/2016
1	CalciumIBA 12/2016
1	CarrageenanIBA 08/2012
1	3- (hydroxymethyl)- 4- (5- methylpyridin- 2- yl)- N- (6- (2,2,2- trifluoroethoxy)pyridin- 3- yl)- 3,4- dihydro- 2H- benzo(b)(1,4)oxazine- 8- carboxamideIBA 08/2012
1	Capsaicin (Zostrix)FDA Link 08/2012
1	Anabolic AgentsIBA 10/2011
1	JTT 305IBA 10/2011
1	Parathyroid Hormone (Parathormone)IBA 03/2011
1	naftopidilIBA 01/2011
1	Leuprolide (Lupron)FDA LinkGeneric 03/2009
1	Nonsteroidal Anti-AndrogensIBA 03/2009
1	Prostate-Specific Antigen (Semenogelase)IBA 12/2008
1	Epirubicin (Ellence)FDA LinkGeneric 10/2002
1	4- ((2- amidino- 1,2,3,4- tetrahydroisoquinolin- 7- yloxy)methyl)- 1- (4- pyridinyl)piperidine- 4- carboxylic acid monomethanesulfonate trihydrateIBA 09/2002
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 09/2002
1	Factor Xa InhibitorsIBA 09/2002

Therapy/Procedure

8	Therapeutics 06/2022 - 10/2002
4	Oral Administration 01/2018 - 06/2002
1	Drug Therapy (Chemotherapy) 06/2022
1	Heterologous Transplantation (Xenotransplantation) 06/2022
1	Long-Term Care 01/2022
1	Denervation 01/2021
1	Injections 03/2011
1	Sutures (Suture) 11/2007
1	Adjuvant Chemotherapy 10/2002
1	Intravesical Administration 10/2002
1	Renal Dialysis (Hemodialysis) 09/2002